126 related articles for article (PubMed ID: 2079572)
1. Treatment of chronic hepatitis B with interferon alfa-2b.
Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; Von Wussow P; Meisel H; Klein H
J Hepatol; 1990; 11 Suppl 1():S137-40. PubMed ID: 2079572
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic hepatitis B with interferon alpha-2b].
Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
[TBL] [Abstract][Full Text] [Related]
4. Low dose alpha interferon treatment in chronic hepatitis B virus infection.
Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; von Wussow P; Meisel H; Klein H
Gut; 1993; 34(2 Suppl):S97-8. PubMed ID: 8314499
[TBL] [Abstract][Full Text] [Related]
5. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
Perez V; Tanno H; Villamil F; Fay O
J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
9. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel AP
J Hepatol; 1990; 11 Suppl 1():S126-8. PubMed ID: 2079569
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic hepatitis B with interferon alpha-2b].
Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; von Wussow P; Meisel H; Klein H
Dtsch Med Wochenschr; 1990 Mar; 115(11):403-7. PubMed ID: 2178900
[TBL] [Abstract][Full Text] [Related]
11. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience.
Weiland O; Schvarcz R; Wejstål R; Norkrans G; Frydén A
J Hepatol; 1990; 11 Suppl 1():S57-62. PubMed ID: 2127789
[TBL] [Abstract][Full Text] [Related]
12. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
Realdi G; Fattovich G; Pastore G; Caredda F; Noventa F; Santantonio T; Moroni M; Criscuolo D; Maladorno D; Rugge M
J Hepatol; 1990; 11 Suppl 1():S129-32. PubMed ID: 2079570
[TBL] [Abstract][Full Text] [Related]
13. Interferon for hepatitis B: US experience.
Perrillo RP
Gut; 1993; 34(2 Suppl):S95-6. PubMed ID: 8314498
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B genotypes and the response to interferon therapy.
Kao JH; Wu NH; Chen PJ; Lai MY; Chen DS
J Hepatol; 2000 Dec; 33(6):998-1002. PubMed ID: 11131465
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]